Orally delivered microencapsulated probiotic formulation favorably impacts polyp formation in APC (Min/+) model of intestinal carcinogenesis

Aleksandra Malgorzata UrbanskaBiomedical Technology and Cell Therapy Research Laboratory, Departments of Biomedical Engineering and Physiology Artificial cells and Organs Research Center, Faculty of Medicine, McGill University, University Street, Montreal, QC, Canada

Jasmine BhathenaBiomedical Technology and Cell Therapy Research Laboratory, Departments of Biomedical Engineering and Physiology Artificial cells and Organs Research Center, Faculty of Medicine, McGill University, University Street, Montreal, QC, Canada

Sofiane CherifBiomedical Technology and Cell Therapy Research Laboratory, Departments of Biomedical Engineering and Physiology Artificial cells and Organs Research Center, Faculty of Medicine, McGill University, University Street, Montreal, QC, Canada

Satya PrakashBiomedical Technology and Cell Therapy Research Laboratory, Departments of Biomedical Engineering and Physiology Artificial cells and Organs Research Center, Faculty of Medicine, McGill University, University Street, Montreal, QC, Canada

Orally delivered microencapsulated probiotic formulation favorably impacts polyp formation in APC (Min/+) model of intestinal carcinogenesis

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Orally delivered microencapsulated probiotic formulation favorably impacts polyp formation in APC (Min/+) model of intestinal carcinogenesis

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date